新日本科学（2395） – Summary of Financial Results for the third quarter 2022

Document and entity informationMar 2022Dec 2021Company informationCompany informationFASF member markDocument nameFiling dateCompany nameStock exchange listingsTokyoTokyo 1st sectionTokyo 2nd sectionTokyo MothersTokyo JASDAQTokyo PRO MarketTokyo OthersNagoya 1st sectionNagoya 2nd sectionNagoya CentrexNagoya OthersNagoyaSapporoSapporoSapporo AmbitiousSapporo OthersFukuokaFukuokaFukuoka Q-BoardFukuoka OthersPhoenixSecurities codeURLBusiness categoryGeneral BusinessSpecific BusinessFiscal Year EndQuarterly periodRepresentativeInquiriesTitleNameTitleNameTelOtherJapan Securities Dealers AssociationQuarterly statement filing date (as planned)Supplemental material of quarterly resultsWay of gettingConvening briefing of quarterly resultsTarget for briefing of quarterly resultsNote to fraction processing methodtrue3truetrue2022-02-02SHIN NIPPONBIOMEDICALLABORATORIES,LTD.———————–true-2022-03-3123950https://www.snbl.co.jp/3IRO03-5565-62162022-02-02trueBusiness Results-Quarterly operating results(in millions of yens)Dec 2021Dec 2020Quarterly operating resultsQuarterly operating resultsConsolidated operating resultsConsolidated income statements informationNet salesNet sales% changeOperating profitOperating profit% changeOrdinary profitOrdinary profit% changeProfit attributable to owners of parentProfit attributable to owners of parent% changeNote to consolidated income statements informationComprehensive incomeComprehensive incomeChange in comprehensive incomeOther consolidated operating resultsBasic earnings per share (Yen)Diluted earnings per share (Yen)Note to consolidated operating resultsNote to operating resultsQuarterly financial positionsQuarterly financial positionsConsolidated financial positionsTotal assetsNet assetsCapital adequacy ratio (%)Net assets per share (Yen)Note to consolidated financial positionsOwner’s equityNote to financial positionsQuarterly note to business resultsQuarterly note to business resultsNote to consolidated financial resultsNote to consolidated financial resultsBusiness Results-Quarterly financial positions(in millions of yens)Dec 2021Mar 2021Business Results-Note to quarterly business resultsQuarterly Dividends(in millions of yens)Quarterly dividendsMar 2022Dec 2021Mar 202112,94624.23,300103.04,684184.55,247255.410,4203.51,6263.11,646-23.11,476-8.03,633-1,369126.0535.4737,36618,70749.7446.1918,57636,97215,83842.6377.9415,734Dec 2021————-0.0040.0040.0020222022Correction of dividend forecast from the most recent dividend forecastCorrection of dividend forecast from the most recent dividend forecasttrueQuarterly Forecasts(in millions of yens)Quarterly dividendsDividendsDividend per share (Yen)Dividend per share (Yen)First quarterResultSecond quarterResultThird quarterResultYear endAnnualResultForecastUpperLowerResultForecastUpperLowerAnnualNote to dividendsNote to dividendsAnnualQuarterly forecastsQuarterly forecastsTitle for forecastsPreamble to consolidated forecastsPreamble to forecastsMain table of consolidated forecastsNet salesNet sales% changeForecastUpperLowerForecastUpperLowerForecastUpperLowerForecastUpperOperating profitOperating profit% change———-0.0020.0020.0017,90018.54,10062.1Mar 20223. 202231431202132022LowerOrdinary profitOrdinary profit% changeForecastUpperLowerForecastUpperLowerForecastUpperLowerForecastUpperLowerForecastUpperLowerProfit attributable to owners of parentProfit attributable to owners of parent% changeBasic earnings per share (Yen)Basic earnings per share (Yen)Note to consolidated forecastsNote to forecastsCorrection of financial forecast from the most recent financial forecastCorrection of financial forecast from the most recent financial forecastForecastNotes, Quarterly-Material changes in subsidiaries during this period changesin scope of consolidations resulting from change in subsidiariesMaterial changes in subsidiaries during this period (Changes in scope ofconsolidations resulting from change is subsidiaries)Material changes in subsidiaries during this period (Changes in scope ofconsolidations resulting from change is subsidiaries)OthersMaterial changes in subsidiaries during this period (Changes in scopeof consolidations resulting from change is subsidiaries)Material changes in subsidiaries during this period (Changes inscope of consolidations resulting from change is subsidiaries)Note to material changes in subsidiaries during this periodNote to material changes in subsidiaries during this periodApplying of specific accounting of the consolidated quarterly financial statementsApplying of specific accounting of the consolidated quarterly financialstatementsOthersApplying of specific accounting of the consolidated quarterly financialstatementsNotes, Quarterly-Applying of specific accounting of the consolidated quarterlyfinancial statements5,63054.45,80058.4139.31————-20222022trueDec 2021Dec 2021Applying of specific accounting of the consolidated quarterlyfinancial statementsNote to applying of specific accounting of the consolidated quarterlyfinancial statementsNote to applying of specific accounting of the consolidatedquarterly financial statementsNotes, Quarterly-Changes in accounting policies and accounting estimatesretrospective restatementChanges in accounting policies, accounting estimates and retrospectiverestatementChanges in accounting policies, accounting estimates and retrospectiverestatementOthersChanges in accounting policies, accounting estimates andretrospective restatementChanges in accounting policies based on revisions of accountingstandardChanges in accounting policies other than ones based onrevisions of accounting standardChanges in accounting estimatesRetrospective restatementNote to changes in accounting policies, accounting estimates andretrospective restatementNote to changes in accounting policies, accounting estimates andretrospective restatement—–Dec 2021trueP. 10Notes, Quarterly-Number of issued and outstanding shares common stockDec 2021Mar 2021Dec 2020Number of issued and outstanding shares (common stock)Number of issued and outstanding shares (common stock)OthersNumber of issued and outstanding shares (common stock)Number of issued and outstanding shares at the end of fiscal year(including treasury stock)41,632,40041,632,400Number of treasury stock at the end of fiscal yearAverage number of shares36141,632,04135841,632,042Note to number of issued and outstanding shares (common stock)Note to number of issued and outstanding shares (common stock)-This information is a summary of the earnings report. It does not contain all details included in the earnings report disclosed in Japanese.